UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial

Journal of clinical oncology, 2019-11, Vol.37 (31), p.2825-2834

2019

Volltextzugriff (PDF)

Advances in immunotherapy for cervical cancer

Current opinion in oncology, 2020-09, Vol.32 (5), p.481-487

2020

Volltextzugriff (PDF)

The SHAPE trial: is good is good enough?

Journal of Gynecologic Oncology, 2024, 35(4), , pp.1-4

Naumann, R Wendel

2024

Volltextzugriff (PDF)

Toolbox for atomic layer deposition process development on high surface area powders

Review of scientific instruments, 2021-02, Vol.92 (2)

2021

Volltextzugriff (PDF)

Minimally Invasive Radical Hysterectomy Has Many Benefits Compared with Open Radical Hysterectomy: Will the LACC Trial Cause the Premature Demise of This Procedure?

Journal of minimally invasive gynecology, 2019-03, Vol.26 (3), p.379-380

Naumann, R. Wendel

2019

Volltextzugriff (PDF)

Re-evaluating “Success” as It Pertains to Surgical Trials

Journal of minimally invasive gynecology, 2021-03, Vol.28 (3), p.496-501

Naumann, R. Wendel

2021

Volltextzugriff (PDF)

Role of Minimally Invasive Surgery in Gynecologic Oncology: An Updated Survey of Members of the Society of Gynecologic Oncology

International journal of gynecological cancer, 2015-07, Vol.25 (6), p.1121-1127

2015

Volltextzugriff (PDF)

The role of lymphadenectomy in endometrial cancer: Was the ASTEC trial doomed by design and are we destined to repeat that mistake?

Gynecologic oncology, 2012-07, Vol.126 (1), p.5-11

Naumann, R. Wendel

2012

Volltextzugriff (PDF)

The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage

American journal of obstetrics and gynecology, 2021-10, Vol.225 (4), p.397.e1-397.e6

2021

Volltextzugriff (PDF)

High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)

Leukemia, 2017-04, Vol.31 (4), p.846-852

2017

Volltextzugriff (PDF)

Atomic layer deposition on porous powders with in situ gravimetric monitoring in a modular fixed bed reactor setup

Review of scientific instruments, 2017-07, Vol.88 (7)

2017

Volltextzugriff (PDF)

Phase II study of treatment of advanced ovarian cancer with folate-receptor-targeted therapeutic (vintafolide) and companion SPECT-based imaging agent (99mTc-etarfolatide)

Annals of oncology, 2014-04, Vol.25 (4), p.852-858

2014

Volltextzugriff (PDF)

Management Strategies for Recurrent Platinum-Resistant Ovarian Cancer

Drugs (New York, N.Y.), 2011-01, Vol.71 (11), p.1397-1412

2011

Volltextzugriff (PDF)

Ovarian cancer screening with the Risk of Ovarian Cancer Algorithm (ROCA): Good, bad, or just expensive?

Gynecologic oncology, 2018-04, Vol.149 (1), p.117-120

2018

Volltextzugriff (PDF)

The Role of Colonoscopy and Radiological Procedures in the Management of Acute Lower Intestinal Bleeding

Clinical gastroenterology and hepatology, 2010-04, Vol.8 (4), p.333-343

2010

Volltextzugriff (PDF)

Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1–2, open-label, multicohort trial

The lancet oncology, 2024-05, Vol.25 (5), p.588-602

2024

Volltextzugriff (PDF)

PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer

Journal of clinical oncology, 2013-12, Vol.31 (35), p.4400-4406

2013

Volltextzugriff (PDF)

Phase III trials in ovarian cancer: The evolving landscape of front line therapy

Gynecologic oncology, 2019-05, Vol.153 (2), p.436-444

2019

Volltextzugriff (PDF)

Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Journal of clinical oncology, 2022-08, Vol.40 (23), p.JCO2101801-2577

2022

Volltextzugriff (PDF)

The Benefits of Laparoscopic Radical Hysterectomy for Cervical Cancer: Res Ipsa Loquitur?

Journal of minimally invasive gynecology, 2022-07, Vol.29 (7), p.805-806

2022

Volltextzugriff (PDF)

Randomized Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer

Journal of clinical oncology, 2007-07, Vol.25 (19), p.2811-2818

2007

Volltextzugriff (PDF)

Workplace Harassment and Discrimination in Gynecology: Results of the AAGL Member Survey

Journal of minimally invasive gynecology, 2019-07, Vol.26 (5), p.838-846

2019

Volltextzugriff (PDF)

Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis

Gynecologic oncology, 2020-07, Vol.158 (1), p.16-24

2020

Volltextzugriff (PDF)

Improved Rates of Same-day Discharge in Patients Undergoing Surgery for Endometrial Cancer Following the COVID-19 Pandemic

Journal of minimally invasive gynecology, 2022-11, Vol.29 (11), p.1248-1252

2022

Volltextzugriff (PDF)

The role of the phosphatidylinositol 3-kinase (PI3K) pathway in the development and treatment of uterine cancer

Gynecologic oncology, 2011-11, Vol.123 (2), p.411-420

Naumann, R. Wendel

2011

Volltextzugriff (PDF)

1 – 25 von 2.561

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.025)
Mit Volltextzugriff
(2.169)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)
... seit 90 Tagen
(15)

Menü

Weitere Dienste

Einstellungen

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial

Advances in immunotherapy for cervical cancer

The SHAPE trial: is good is good enough?

Toolbox for atomic layer deposition process development on high surface area powders

Minimally Invasive Radical Hysterectomy Has Many Benefits Compared with Open Radical Hysterectomy: Will the LACC Trial Cause the Premature Demise of This Procedure?

Re-evaluating “Success” as It Pertains to Surgical Trials

Role of Minimally Invasive Surgery in Gynecologic Oncology: An Updated Survey of Members of the Society of Gynecologic Oncology

The role of lymphadenectomy in endometrial cancer: Was the ASTEC trial doomed by design and are we destined to repeat that mistake?

The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage

High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)

Atomic layer deposition on porous powders with in situ gravimetric monitoring in a modular fixed bed reactor setup

Phase II study of treatment of advanced ovarian cancer with folate-receptor-targeted therapeutic (vintafolide) and companion SPECT-based imaging agent (99mTc-etarfolatide)

Management Strategies for Recurrent Platinum-Resistant Ovarian Cancer

Ovarian cancer screening with the Risk of Ovarian Cancer Algorithm (ROCA): Good, bad, or just expensive?

The Role of Colonoscopy and Radiological Procedures in the Management of Acute Lower Intestinal Bleeding

Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1–2, open-label, multicohort trial

PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer

Phase III trials in ovarian cancer: The evolving landscape of front line therapy

Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

The Benefits of Laparoscopic Radical Hysterectomy for Cervical Cancer: Res Ipsa Loquitur?

Randomized Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer

Workplace Harassment and Discrimination in Gynecology: Results of the AAGL Member Survey

Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis

Improved Rates of Same-day Discharge in Patients Undergoing Surgery for Endometrial Cancer Following the COVID-19 Pandemic

The role of the phosphatidylinositol 3-kinase (PI3K) pathway in the development and treatment of uterine cancer

Suchergebnisse filtern